Organoid Cultures Derived from Patients with Advanced Prostate Cancer
A
B
Figure1.CopyNumberLandscapeofPatientDerivedProstateCancerOrganoidLines
(A)Top:Signi cantgenomicaberrationsintheprostateoncogenomefromtheMSKCCCGHdatasetadoptedfrom(Tayloretal.,2010).Bottom:Copynumberlandscapeofsevenpatient-derivedorganoidlinesandsixpublicallyavailableprostatecancercelllinesusingarrayCGHdata.Shadesofredandbluerepresentlevelofgainandloss.
(B)Copynumberchangesatchromosome3p14containingFOXP1,SHQ1,andRYBP,theCHD1locus,thePTENlocus,theTMPRSS2-ERGlocusandtheARlocus.Arrowspointtohighlyfocalregionsofbiallelicdeletion.SeealsoFigureS1forzoomedviewtogetherwithcorroboratingRNA-seqandWESreads.
shown),whichweinterpretasmoreconsistentwiththelinesorig-inatingfromnormalliverorlungepithelialcellsratherthanfromprostatecancer.Indeed,othershavereportedthatthegrowthconditionsusedherearebroadlyconducivetogrowthofmultiplenormalepithelialcelltypes(Barkeretal.,2010;Huchetal.,2013a;Huchetal.,2013b;Satoetal.,2009).Strategiestoselec-tivelyisolatetumorfromthenormalepithelialandstromalcellspresentinbiopsiesmightovercomethisproblem.Inaddition,evaluationofotherconditionstoimproveprimaryepithelialgrowthsuchascoculturewithstromalcellsandROCKinhibitor(Liuetal.,2012b)mightfurtherenhanceef ciency.Nonetheless,thederivationofsevennewlinesover 9monthseffectivelydou-blesthenumberofexistingprostatecancercelllines.
Patient-DerivedOrganoidLinesHaveCopyNumberAlterationSignaturesofAggressiveProstateCancer
Stereotypicrecurrentcopynumberchangesfoundinhigh-gradeprimaryandmetastaticprostatecancerincludegainsofchromosome7and8qandlossesofchromosome5q,6q,8p,13q,and18q(Demichelisetal.,2009;Grassoetal.,2012;Tay-loretal.,2010).Thesevenprostatecancerorganoidlinesdescribedhereexhibitmanyofthesetypicalcopynumberalterations,evenmoresothancurrentlyavailableprostatecancercelllines(Figure1A).Forexample,MSK-PCa1andMSK-PCa3exhibittheTMPRSS2-ERGinterstitialdeletion,andMSK-PCa1andMSK-PCa7harborfocalheterozygousdeletionofSHQ1andRYBP,bothofwhichmaptoaregionchromosome3p14previouslyshowntospanthecandidatetu-morsuppressorsFOXP1,SHQ1,andRYBP(Krohnetal.,2013;Tayloretal.,2010).
Threeorganoidlines(MSK-PCa2,MSK-PCa4,andMSK-PCa7)containfocalhomozygousdeletionsofchromodomainhelicaseDNAbindingprotein1(CHD1),thatresultsincompletelossofproteinexpression(Figure1B,alsoseeFigure4B).CHD1isthesecondmostcommonlyhomozygousdeletedgeneinprostatecancer(Burkhardtetal.,2013;Liuetal.,2012a).In

MSK-PCa2,
Cell159,1–12,September25,2014ª2014ElsevierInc.

3
from patients with advanced prostate, bladder, or breast cancer as well as...Regardless of whether the peptidome is derived from the tissue/microenvironment...
[6], advanced melanoma [11], prostate cancer [...from healthy donors and from patients with chronic...In DC cultures of four healthy donors, Freezing ...
热门文档